Repare Therapeutics Inc.
RPTXDelisted Jan 28, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808158
Repare Therapeutics Inc. was delisted on Jan 28, 2026; its insiders filed their last Form 4 on Jan 30, 2026; 46 institutions reported holding it in 13F filings for Q4 2025, worth $65.4M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 46
- Q4 2025, +2 vs. previous quarter
- 13F value
- $65.4M
- Reported value at the end of Q4 2025
- Superinvestors holding
- 0
- At the end of Q4 2025
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2024
- –
- No comparable prior period
- Net income, FY2024
- -$84.7M
- No comparable prior period
- Free cash flow, FY2024
- -$76.4M
- No comparable prior period
- Revenue, Q3 FY2025
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Jan 15, 2026.
- Short interest
- 437.9K
- Shares sold short
- Change
- +243.6K
- +125.3% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding RPTX, Q4 2025
Go to the superinvestors tabNo superinvestor reported holding RPTX at the end of Q4 2025.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Repare Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Koehler MariaEVP, CHIEF MEDICAL OFFICER | SSale | −3.60K | $1.14 | −$4.10K | −1.6%227.8K after | |
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER | SSale | −5.61K | $1.14 | −$6.40K | −6.5%80.3K after | |
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Forte SteveEVP, CHIEF FINANCIAL OFFICER | SSale | −6.88K | $1.14 | −$7.85K | −11.2%54.8K after | |
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Segal Lloyd MitchellPRESIDENT AND CEO | SSale | −21.2K | $1.14 | −$24.1K | −14.5%124.4K after | |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Segal Lloyd MitchellPRESIDENT AND CEO | SSale | −5.14K | $4.62 | −$23.8K | −4.6%107.6K after | 2 lots10b5-1 |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Forte SteveEVP, CHIEF FINANCIAL OFFICER | SSale | −1.61K | $4.62 | −$7.45K | −3.5%44.8K after | 2 lots10b5-1 |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER | SSale | −860 | $4.65 | −$4.00K | −1.2%71.9K after | 2 lots10b5-1 |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Koehler MariaEVP, CHIEF MEDICAL OFFICER | SSale | −800 | $4.65 | −$3.72K | −0.3%231.4K after | 2 lots10b5-1 |
| Mar 27, 2024 (view filing) | Mar 25-27 | 2 days | Forte SteveEVP, CHIEF FINANCIAL OFFICER | SSale | −2.48K | $4.67 | −$11.6K | −5.5%42.2K after | 3 lots10b5-1 |
| Mar 27, 2024 (view filing) | Mar 25-27 | 2 days | Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICER | SSale | −1.35K | $4.67 | −$6.30K | −1.8%72.8K after | 3 lots10b5-1 |
Top 10 13F holders, Q4 2025
See all 46 holdersThe largest institutional positions in Repare Therapeutics Inc. at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 10,333,600 | $26.9M | 0.90% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,443,659 | $8.95M | 2.76% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,322,488 | $8.64M | 0.18% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,586,174 | $4.12M | 0.30% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 1,287,829 | $3.35M | 2.88% | +641,953+99.4% | Added |
| Marshall Wace, LLP | 1,115,744 | $2.90M | 0.00% | +1,115,744 | New |
| Renaissance Technologies LLC | 981,360 | $2.55M | 0.00% | +257,200+35.5% | Added |
| Acadian Asset Management LLC | 618,672 | $1.61M | 0.00% | +50,371+8.9% | Added |
| Two Sigma Investments, LP | 333,694 | $867.6K | 0.00% | +322,727+2,942.7% | Added |
| Jane Street Group, LLC | 278,304 | $723.6K | 0.00% | +278,304 | New |
Holders of 5% or more of RPTX
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Repare Therapeutics Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Shay Capital LLC | 13G | 6.70%2.87M shares | New | Jan 27, 20261 filing | Jan 27, 2026 | SEC |